These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23664438)

  • 21. Thrombospondin-4 and its variants: expression and differential effects on endothelial cells.
    Stenina OI; Desai SY; Krukovets I; Kight K; Janigro D; Topol EJ; Plow EF
    Circulation; 2003 Sep; 108(12):1514-9. PubMed ID: 12952849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of thrombospondin-1 in vessel wall of diabetic Zucker rat.
    Stenina OI; Krukovets I; Wang K; Zhou Z; Forudi F; Penn MS; Topol EJ; Plow EF
    Circulation; 2003 Jul; 107(25):3209-15. PubMed ID: 12810612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1.
    Tan BK; Adya R; Chen J; Farhatullah S; Heutling D; Mitchell D; Lehnert H; Randeva HS
    Cardiovasc Res; 2009 Aug; 83(3):566-74. PubMed ID: 19414528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelets, thrombospondin-1 and human dermal fibroblasts cooperate for stimulation of endothelial cell tubulogenesis through VEGF and PAI-1 regulation.
    Kellouche S; Mourah S; Bonnefoy A; Schoëvaert D; Podgorniak MP; Calvo F; Hoylaerts MF; Legrand C; Dosquet C
    Exp Cell Res; 2007 Feb; 313(3):486-99. PubMed ID: 17126831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombospondin orchestrates the tolerance-promoting properties of TGFbeta-treated antigen-presenting cells.
    Masli S; Turpie B; Streilein JW
    Int Immunol; 2006 May; 18(5):689-99. PubMed ID: 16569680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of G proteins in thromospondin-1-induced vascular smooth muscle cell migration.
    Fuse S; Esemuede N; Yamaguchi M; Maier KG; Nesselroth SM; Sumpio BE; Gahtan V
    Surgery; 2008 Jul; 144(1):86-92. PubMed ID: 18571589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of CD36 molecular features required for its in vitro angiostatic activity.
    Primo L; Ferrandi C; Roca C; Marchiò S; di Blasio L; Alessio M; Bussolino F
    FASEB J; 2005 Oct; 19(12):1713-5. PubMed ID: 16037098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma.
    Tanaka K; Sonoo H; Kurebayashi J; Nomura T; Ohkubo S; Yamamoto Y; Yamamoto S
    Clin Cancer Res; 2002 May; 8(5):1125-31. PubMed ID: 12006528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A TSP-1 functional fragment inhibits activation of latent transforming growth factor-beta1 derived from rat alveolar macrophage after bleomycin treatment.
    Chen Y; Wang X; Weng D; Tao S; Lv L; Chen J
    Exp Toxicol Pathol; 2009 Jan; 61(1):67-73. PubMed ID: 18722097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A motif within the N-terminal domain of TSP-1 specifically promotes the proangiogenic activity of endothelial colony-forming cells.
    Dias JV; Benslimane-Ahmim Z; Egot M; Lokajczyk A; Grelac F; Galy-Fauroux I; Juliano L; Le-Bonniec B; Takiya CM; Fischer AM; Blanc-Brude O; Morandi V; Boisson-Vidal C
    Biochem Pharmacol; 2012 Oct; 84(8):1014-23. PubMed ID: 22796565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of thrombospondin-1-derived peptide, 4N1K, in FGF-2-induced angiogenesis.
    Kanda S; Shono T; Tomasini-Johansson B; Klint P; Saito Y
    Exp Cell Res; 1999 Nov; 252(2):262-72. PubMed ID: 10527617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current understanding of the thrombospondin-1 interactome.
    Resovi A; Pinessi D; Chiorino G; Taraboletti G
    Matrix Biol; 2014 Jul; 37():83-91. PubMed ID: 24476925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cell biology of thrombospondin-1.
    Chen H; Herndon ME; Lawler J
    Matrix Biol; 2000 Dec; 19(7):597-614. PubMed ID: 11102749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of thrombospondin‑1 and thrombospondin‑2 in cardiovascular diseases (Review).
    Zhang K; Li M; Yin L; Fu G; Liu Z
    Int J Mol Med; 2020 May; 45(5):1275-1293. PubMed ID: 32323748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling.
    Isenberg JS; Frazier WA; Krishna MC; Wink DA; Roberts DD
    Curr Drug Targets; 2008 Oct; 9(10):833-41. PubMed ID: 18855617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased cardiovascular mortality in females with the a/a genotype of the SNPs rs1478604 and rs2228262 of thrombospondin-1.
    Alehagen U; Shamoun L; Wågsäter D
    BMC Med Genet; 2020 Sep; 21(1):179. PubMed ID: 32917134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human expression patterns: qualitative and quantitative analysis of thrombospondin-1 under physiological and pathological conditions.
    Zhao C; Isenberg JS; Popel AS
    J Cell Mol Med; 2018 Apr; 22(4):2086-2097. PubMed ID: 29441713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action.
    Rusnati M; Urbinati C; Bonifacio S; Presta M; Taraboletti G
    Pharmaceuticals (Basel); 2010 Apr; 3(4):1241-1278. PubMed ID: 27713299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The molecular mechanism of thrombospondin family members in cardiovascular diseases.
    Pan H; Lu X; Ye D; Feng Y; Wan J; Ye J
    Front Cardiovasc Med; 2024; 11():1337586. PubMed ID: 38516004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial Cell Behavior Is Determined by Receptor Clustering Induced by Thrombospondin-1.
    Morandi V; Petrik J; Lawler J
    Front Cell Dev Biol; 2021; 9():664696. PubMed ID: 33869231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.